-
AbbVie Inc. (ABBV $227.44)
-
Danaher Corporation (DHR $207.46)
-
Eli Lilly and Company (LLY $1,018.62)
-
Thermo Fisher Scientific Inc (TMO $510.92)
-
Lantheus Holdings Inc. (LNTH $72.22)
Q: As I'm sure you're aware, this is a name that has been drifting steadily lower since it ranked on its disappointing latest earnings release. Do you think it remains a premier us drug manufacturer worth holding or would you recommend redeploying the capital into another name?